Christoph Wetz

539 total citations
26 papers, 335 citations indexed

About

Christoph Wetz is a scholar working on Epidemiology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christoph Wetz has authored 26 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 12 papers in Oncology and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christoph Wetz's work include Neuroendocrine Tumor Research Advances (12 papers), Neuroblastoma Research and Treatments (8 papers) and Lung Cancer Research Studies (8 papers). Christoph Wetz is often cited by papers focused on Neuroendocrine Tumor Research Advances (12 papers), Neuroblastoma Research and Treatments (8 papers) and Lung Cancer Research Studies (8 papers). Christoph Wetz collaborates with scholars based in Germany and Austria. Christoph Wetz's co-authors include Holger Amthauer, Henning Jann, Christoph Roderburg, Bertram Wiedenmann, Alexander Wree, Frank Tacke, Antonin Kayser, Christian Furth, Imke Schatka and Julian M.M. Rogasch and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Christoph Wetz

22 papers receiving 331 citations

Peers

Christoph Wetz
Norbert Zsótér Germany
Virginia Liberini Italy
Xiaoming Zhou China
Giulia Polverari Italy
Silvia Ortolani Italy
Giuseppe Corrias Italy
Matthew Aldridge United Kingdom
Helena Leijon Finland
Johanna M. Zuetenhorst Netherlands
Emilio Mezzenga Italy
Norbert Zsótér Germany
Christoph Wetz
Citations per year, relative to Christoph Wetz Christoph Wetz (= 1×) peers Norbert Zsótér

Countries citing papers authored by Christoph Wetz

Since Specialization
Citations

This map shows the geographic impact of Christoph Wetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Wetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Wetz more than expected).

Fields of papers citing papers by Christoph Wetz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Wetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Wetz. The network helps show where Christoph Wetz may publish in the future.

Co-authorship network of co-authors of Christoph Wetz

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Wetz. A scholar is included among the top collaborators of Christoph Wetz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Wetz. Christoph Wetz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bayerl, Christian, Julian M.M. Rogasch, Christian Furth, et al.. (2024). 68Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapy. Theranostics. 14(11). 4184–4197. 3 indexed citations
3.
Knebel, Fabian, Sebastian Spethmann, Daniel Messroghli, et al.. (2024). Neurological affection and serum neurofilament light chain in wild type transthyretin amyloidosis. Scientific Reports. 14(1). 10111–10111. 2 indexed citations
4.
Rogasch, Julian M.M., Christoph Wetz, Winfried Brenner, et al.. (2023). Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors. EJNMMI Research. 13(1). 24–24. 1 indexed citations
5.
6.
Rogasch, Julian M.M., Winfried Brenner, Christoph Wetz, et al.. (2023). ChatGPT: Can You Prepare My Patients for [18F]FDG PET/CT and Explain My Reports?. Journal of Nuclear Medicine. 64(12). 1876–1879. 28 indexed citations
7.
Mogl, Martina T., Robert Öllinger, Henning Jann, et al.. (2022). Differenzierte Therapiestrategie bei Lebermetastasen gastro-entero-pankreatischer Neuroendokriner Neoplasien. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 147(3). 270–280. 1 indexed citations
8.
9.
Kleefeld, Felix, Fabian Knebel, Daniel Messroghli, et al.. (2022). Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis. Amyloid. 29(2). 92–101. 12 indexed citations
10.
Schatka, Imke, Daniel Messroghli, Fabian Knebel, et al.. (2021). An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis. Journal of Nuclear Cardiology. 28(6). 2483–2496. 8 indexed citations
11.
Rogasch, Julian M.M., Kai Huang, Henning Jann, et al.. (2021). The prognostic value of the De Ritis ratio on progression free survival in patients with NET undergoing [177Lu]Lu-DOTATOC-PRRT: A retrospective analysis. Nuklearmedizin - NuclearMedicine. 1 indexed citations
12.
Mogl, Martina T., et al.. (2020). Influence of Gender on Therapy and Outcome of Neuroendocrine Tumors of Gastroenteropancreatic Origin: A Single-Center Analysis. Visceral Medicine. 36(1). 20–27. 6 indexed citations
13.
Senger, Carolin, Christoph Wetz, Alexander Baur, et al.. (2020). Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume Definition. Diagnostics. 10(12). 1084–1084. 3 indexed citations
14.
Rogasch, Julian M.M., Christoph Wetz, & Winfried Brenner. (2020). TI-RADS und andere sonografische Klassifikationssysteme für Schilddrüsenknoten. 13(1). E1–E13.
15.
Wetz, Christoph, Ivayla Apostolova, Christian Furth, et al.. (2019). The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [177Lu]-DOTATATE. PLoS ONE. 14(5). e0216781–e0216781. 15 indexed citations
16.
Kayser, Antonin, Christoph Wetz, Holger Amthauer, et al.. (2019). Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. International Journal of Molecular Sciences. 20(12). 3049–3049. 138 indexed citations
17.
Wetz, Christoph, et al.. (2018). Pre-operative quantification of pulmonary function using hybrid-SPECT/low-dose-CT: A pilot study. Lung Cancer. 118. 155–160. 10 indexed citations
18.
Kupitz, Dennis, Christoph Wetz, Ivayla Apostolova, et al.. (2017). Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios. PLoS ONE. 12(11). e0187570–e0187570. 28 indexed citations
19.
Wetz, Christoph, Ivayla Apostolova, Ingo G. Steffen, et al.. (2016). Predictive Value of Asphericity in Pretherapeutic [111In]DTPA-Octreotide SPECT/CT for Response to Peptide Receptor Radionuclide Therapy with [177Lu]DOTATATE. Molecular Imaging and Biology. 19(3). 437–445. 27 indexed citations
20.
Rief, Matthias, Elke Zimmermann, Patrick Asbach, et al.. (2013). High-Field Open versus Short-Bore Magnetic Resonance Imaging of the Spine: A Randomized Controlled Comparison of Image Quality. PLoS ONE. 8(12). e83427–e83427. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Norbert Zsótér Breakdown of academic impact, for papers by Virginia Liberini Breakdown of academic impact, for papers by Xiaoming Zhou Breakdown of academic impact, for papers by Giulia Polverari Breakdown of academic impact, for papers by Silvia Ortolani Breakdown of academic impact, for papers by Giuseppe Corrias Breakdown of academic impact, for papers by Matthew Aldridge Breakdown of academic impact, for papers by Helena Leijon Breakdown of academic impact, for papers by Johanna M. Zuetenhorst Breakdown of academic impact, for papers by Emilio Mezzenga
Rankless by CCL
2026